Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
GSK CEO still sees plenty of 'headroom for growth' for RSV shot
Despite Arexvy's swift takeoff, there’s still “lots of headroom for growth," GSK's CEO Emma Walmsley said during a Reuters interview Thursday.
Fraiser Kansteiner
Nov 30, 2023 4:32pm
GSK nears settlement of ‘non-drowsy’ marketing lawsuit
Nov 28, 2023 11:10am
After pulling Blenrep, GSK touts combo trial in multiple myeloma
Nov 27, 2023 10:36am
GSK aims to slash carbon emissions with next-generation inhaler
Nov 21, 2023 10:16am
GSK, ex-"Queer Eye" star launch myelofibrosis education campaign
Nov 13, 2023 9:50am
AbbVie, Boehringer and more face FTC ire for 'improper' patents
Nov 7, 2023 2:22pm
